Trial Outcomes & Findings for Comparison of Total Oxidant and Total Antioxidant Capacities in Low-Flow and High-Flow General Anesthesia (NCT NCT05590312)

NCT ID: NCT05590312

Last Updated: 2025-01-17

Results Overview

Vitamin D, Albumin, CRP, TAS and TOS values will be checked before the operation in 72 patients who will receive general anesthesia in both groups. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the ward after the operation and these values will be compared between two groups and with the previous level in the same group.

Recruitment status

COMPLETED

Target enrollment

72 participants

Primary outcome timeframe

3 times in 24 hours perioperatively. TAS/TOS levels will be determined before the operation, at the end of operation and at 6th hour after the end of operation.

Results posted on

2025-01-17

Participant Flow

Participant milestones

Participant milestones
Measure
Low Flow Group - Group D
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 1 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
High Flow Group - Group Y
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 4 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
Overall Study
STARTED
36
36
Overall Study
COMPLETED
36
36
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Low Flow Group - Group D
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 1 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
High Flow Group - Group Y
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 4 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
Total
n=72 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=36 Participants
0 Participants
n=36 Participants
0 Participants
n=72 Participants
Age, Categorical
Between 18 and 65 years
36 Participants
n=36 Participants
36 Participants
n=36 Participants
72 Participants
n=72 Participants
Age, Categorical
>=65 years
0 Participants
n=36 Participants
0 Participants
n=36 Participants
0 Participants
n=72 Participants
Age, Continuous
34 years
STANDARD_DEVIATION 11 • n=36 Participants
39 years
STANDARD_DEVIATION 12 • n=36 Participants
37 years
STANDARD_DEVIATION 11 • n=72 Participants
Sex: Female, Male
Female
16 Participants
n=36 Participants
15 Participants
n=36 Participants
31 Participants
n=72 Participants
Sex: Female, Male
Male
20 Participants
n=36 Participants
21 Participants
n=36 Participants
41 Participants
n=72 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
Turkey
36 participants
n=36 Participants
36 participants
n=36 Participants
72 participants
n=72 Participants
Fresh gas flow
1 liter/minute
n=36 Participants
4 liter/minute
n=36 Participants
2.5 liter/minute
n=72 Participants

PRIMARY outcome

Timeframe: 3 times in 24 hours perioperatively. TAS/TOS levels will be determined before the operation, at the end of operation and at 6th hour after the end of operation.

Vitamin D, Albumin, CRP, TAS and TOS values will be checked before the operation in 72 patients who will receive general anesthesia in both groups. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the ward after the operation and these values will be compared between two groups and with the previous level in the same group.

Outcome measures

Outcome measures
Measure
Low Flow Group - Group D
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 1 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
High Flow Group - Group Y
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 4 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
Comparison of Total Antioxidant Status (TAS) Levels Between the Two Groups
T0: Before the operation
1.76 mmol Eq / L
Standard Deviation 0.23
1.82 mmol Eq / L
Standard Deviation 0.3
Comparison of Total Antioxidant Status (TAS) Levels Between the Two Groups
T1: At the end of the operation
1.83 mmol Eq / L
Standard Deviation 0.24
1.92 mmol Eq / L
Standard Deviation 0.27
Comparison of Total Antioxidant Status (TAS) Levels Between the Two Groups
T2: At 6th hour after the end of the operation
1.85 mmol Eq / L
Standard Deviation 0.28
1.89 mmol Eq / L
Standard Deviation 0.29

PRIMARY outcome

Timeframe: 3 times in 24 hours perioperatively. TAS/TOS levels will be determined before the operation, at the end of operation and at 6th hour after the end of operation.

Vitamin D, Albumin, CRP, TAS and TOS values will be checked before the operation in 72 patients who will receive general anesthesia in both groups. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the ward after the operation and these values will be compared between two groups and with the previous level in the same group.

Outcome measures

Outcome measures
Measure
Low Flow Group - Group D
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 1 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
High Flow Group - Group Y
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 4 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
Change From Baseline in Total Oxidant Status (TOS) Levels
T0: before the operation
19.82 µmol H2O2 q/L
Standard Deviation 11.82
21.48 µmol H2O2 q/L
Standard Deviation 11.01
Change From Baseline in Total Oxidant Status (TOS) Levels
T1: at the end of operation
19.66 µmol H2O2 q/L
Standard Deviation 11.75
17.20 µmol H2O2 q/L
Standard Deviation 8.72
Change From Baseline in Total Oxidant Status (TOS) Levels
T2: at 6th hour after the end of operation.
22.49 µmol H2O2 q/L
Standard Deviation 11.99
21.38 µmol H2O2 q/L
Standard Deviation 11.64

PRIMARY outcome

Timeframe: 3 times in 24 hours perioperatively. Albumin levels will be determined before the operation, at the end of operation and at 6th hour after the end of operation.

Vitamin D, Albumin, CRP, TAS and TOS values will be checked before the operation in 72 patients who will receive general anesthesia in both groups. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the ward after the operation and these values will be compared between two groups and with the previous level in the same group.

Outcome measures

Outcome measures
Measure
Low Flow Group - Group D
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 1 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
High Flow Group - Group Y
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 4 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
Change From Baseline in Albumin Levels.
T0: before the operation
4.24 mg/dL
Standard Deviation 0.3
4.15 mg/dL
Standard Deviation 0.24
Change From Baseline in Albumin Levels.
T1: at the end of operation
4.05 mg/dL
Standard Deviation 0.38
4.02 mg/dL
Standard Deviation 0.39
Change From Baseline in Albumin Levels.
T2: at 6th hour after the end of operation.
3.96 mg/dL
Standard Deviation 0.36
3.97 mg/dL
Standard Deviation 0.40

PRIMARY outcome

Timeframe: 3 times in 24 hours perioperatively. Albumin levels will be determined before the operation, at the end of operation and at 6th hour after the end of operation.

Vitamin D, Albumin, CRP, TAS and TOS values will be checked before the operation in 72 patients who will receive general anesthesia in both groups. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the ward after the operation and these values will be compared between two groups and with the previous level in the same group.

Outcome measures

Outcome measures
Measure
Low Flow Group - Group D
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 1 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
High Flow Group - Group Y
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 4 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
Change From Baseline in C Reactive Protein (CRP) Levels.
T2: at 6th hour after the end of operation.
1.41 mg/dL
Standard Deviation 2.58
1.37 mg/dL
Standard Deviation 2.31
Change From Baseline in C Reactive Protein (CRP) Levels.
T0: before the operation
0.30 mg/dL
Standard Deviation 0.54
0.53 mg/dL
Standard Deviation 1.61
Change From Baseline in C Reactive Protein (CRP) Levels.
T1: at the end of operation
0.31 mg/dL
Standard Deviation 0.56
0.52 mg/dL
Standard Deviation 1.36

PRIMARY outcome

Timeframe: 1 time before the operation.

Vitamin D, Albumin, CRP, TAS and TOS values will be checked before the operation in 72 patients who will receive general anesthesia in both groups. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the ward after the operation and these values will be compared between two groups and with the previous level in the same group.

Outcome measures

Outcome measures
Measure
Low Flow Group - Group D
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 1 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
High Flow Group - Group Y
n=36 Participants
Vitamin D, Albumin, CRP, TAS and TOS values will be checked before and during the operation in 36 patients who will receive general anesthesia. Flow of 4 L/min will be given during the operation. The processed EEG values of all patients will be monitored and they will be ensured to be at the same anesthesia depth. Albumin, CRP, TAS and TOS values will be checked again from the blood taken postoperatively in the patients who were taken to the service after the operation and these values will be compared with the previous ones. general anesthesia: All patients will undergo general anesthesia. Group D will receive fresh gas flow of 1 l/min and Group Y will receive fresh gas flow of 4 l/min.
Comparison of Vitamin D Levels Between the Two Groups
7.5 mg/dL
Standard Deviation 10.9
14.8 mg/dL
Standard Deviation 13

Adverse Events

Low Flow Group - Group D

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

High Flow Group - Group Y

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Assistant Professor Özlem Ersoy Karka

Düzce University Faculty of Medicine

Phone: +905337293978

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place